3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
32
Thoracic
23
Gastrointestinal
23
Dermatologic
18
Genitourinary
14
Breast
9
Gynecologic
7
Sarcoma
4
Head & Neck
4
Lymphoid
2
CNS
2
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Conditions
Mesothelioma
17
Mesothelioma, Malignant
15
Solid Tumor
10
Carcinoma, Non-Small-Cell Lung
8
Advanced Solid Tumors
8
Melanoma
6
Carcinoma, Renal Cell
5
Carcinoma, Hepatocellular
5
Advanced Solid Tumor
5
Solid Tumors
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Small Cell Lung Carcinoma
3
Ovarian Neoplasms
3
Carcinoma, Transitional Cell
3
Carcinoma, Merkel Cell
3
Advanced or Metastatic Solid Tumors
3
Turcot syndrome
2
Stomach Neoplasms
2
Neoplasm Metastasis
2
Malignant Solid Tumor
2
Lung Neoplasms
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Cholangiocarcinoma
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
pembrolizumab
4
Cisplatin
3
Carboplatin
3
budigalimab
2
Pemetrexed
2
Paclitaxel
2
Immunotherapy
2
Etoposide
2
Drug Therapy
2
Docetaxel
2
Cyclophosphamide
2
venetoclax
1
trametinib
1
spartalizumab
1
sargramostim
1
rovalpituzumab tesirine
1
ribociclib
1
poly ICLC
1
fludarabine
1
enzalutamide
1
entinostat
1
belinostat
1
UV1 vaccine
1
Tomography, Optical Coherence
1
Thrombopoietin
1
Sunitinib
1
Sirolimus
1
Quality of Life
1
Polymerase Chain Reaction
1
Patient Reported Outcome Measures
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Nivolumab
×
Other solid neoplasm
×
Clear all
NCT04300244
2024-02-29
NIPU
Oslo University Hospital
Phase 2
Active not recruiting
118 enrolled